Vascular disease, hypertensive disorder, neoplasms Flashcards
Threshold for pharmacological intervention in hypertension
SBP > 130
DBP > 80
AND one of
- ASCVD- ischaemic heart disease, PAD, previous stroke, congestive HF
- 10-year ASCVD >10%
All adult with SBP >140, DBP >90
First line antihypertensives
ACEi
ARBs
Thiazides
DHP CCB
non-DHP CCB
Second line antihypertensives
Beta-blockers
Loop diuretics
Potassium sparing diuretics
alpha-1 blockers
Direct renin inhibitors (rare)
alpha-2 blockers (rare)
Direct arteriolar vasodilators
When are beta-blockers recommended first-line for HTN
IHD
HF
AF
Thoracic aortic disease
Thyrotoxicosis
Migraine
Essential tremor
When is aldosterone specifically preferred for HTN
Primary hyperaloderism
What antihypertensive is best suited in osteoporosis?
Thiazide diuretics- decreases renal calcium secretion
Follow-up time frame after starting antihypertensives
1 month
- check electrolytes and cr (ARB, ACEi)
Consider 2 weeks in:
- initial hyponatraemia started on thiazide
- CKD with high cr/ K started on ARB/ ACEi
Follow-up time frame for non-pharamacological management of HTN
3-6 months
- start medication if uncontrolled
When to discontinue ACEi/ ARBs for HTN
Cr increase >30% from baseline
Hyperkalaemia
Fluid rentention
Antihypertensive medication titration based on:
- hyponatraemia
- hypokalaemia
- hyperkalaemia
- cough
hyponatraemia
- stop/ avoid thiazide. Consider loop diuretics
hypokalaemia
- exclude hyperaldosteronism
- consider thiazide sparing diuretics
hyperkalaemia
- thiazide diuretics
cough
- switch ACEi to ARBs
Most effective lifestyle intervention for HTN and its SBP reduction
Weight loss
- 1 mmHg for every kilo loss in overweight patients
Most effective diet for HTN and its SBP reduction
DASH diet
- 11 mmHg reduction
Renal biopsy features of chronic aterial hypertenion (hypertensive nephrosclerosis)
arterial/ ateriolar sclerosis
hyalinosis